Loading...
Role of zoledronic acid in the prevention and treatment of osteoporosis
Taken once a year, intravenous zoledronic acid (Zol) (Reclast(®) or Aclasta(®)) is a third-generation nitrogen-containing bisphosphonate that is effective compared with placebo in reducing the risk of fractures in patients with postmenopausal osteoporosis and recent low-trauma hip fracture. In gluco...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3095556/ https://ncbi.nlm.nih.gov/pubmed/21594000 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CIA.S7282 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|